New Key Statistics Module, Z-Score and F-Score
OTCPK:EIGRQ Key Ratios
| Market Cap $ M | 3.14 |
| Enterprise Value $ M | 19.09 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 0.19 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 15.00 |
| EPS (TTM) $ | -51.08 |
| Beneish M-Score | -3.25 |
| 10-y EBITDA Growth Rate % | 29.10 |
| 5-y EBITDA Growth Rate % | 15.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.27 |
| EV-to-EBITDA | -0.28 |
| PEG | -- |
| Shares Outstanding M | 1.48 |
| Net Margin (%) | -475.26 |
| Operating Margin % | -455.12 |
| Pre-tax Margin (%) | -475.22 |
| Quick Ratio | 0.68 |
| Current Ratio | 0.71 |
| ROA % (ttm) | -97.05 |
| ROE % (ttm) | -417.47 |
| ROIC % (ttm) | -439.77 |
| Dividend Yield % | -- |
| Altman Z-Score | -24.41 |
EIGRQ Number of Guru Trades
EIGRQ Volume of Guru Trades
Gurus Latest Trades with OTCPK:EIGRQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:EIGRQ is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Eiger BioPharmaceuticals Inc Insider Transactions
No Available Data
News about OTCPK:EIGRQ
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers